{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:44:10Z","timestamp":1792485850477,"version":"4.5.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01580","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:30:34Z","timestamp":1562718634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Ashanty M.","family":"Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling M.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A. W.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Veerapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdyal S.","family":"Besra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finbar","family":"MacCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayamasami","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacintha","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.178.1.1","article-title":"Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain","volume":"178","author":"Porcelli","year":"1993","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.micinf.2004.12.013","article-title":"Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset","volume":"7","author":"Treiner","year":"2005","journal-title":"Microbes Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161 hi IL-17-secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1084\/jem.189.12.1907","article-title":"An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha\/beta T cell subpopulation in mammals","volume":"189","author":"Tilloy","year":"1999","journal-title":"J Exp Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","article-title":"MR1 presents microbial vitamin B metabolites to MAIT cells","volume":"491","author":"Kjer-Nielsen","year":"2012","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1003681","DOI":"10.1371\/journal.ppat.1003681","article-title":"MAIT cells detect and efficiently lyse bacterially-infected epithelial cells","volume":"9","author":"Le Bourhis","year":"2013","journal-title":"PLoS Pathog"},{"key":"B7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cei.12277","article-title":"Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases","volume":"176","author":"Serriari","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/art.33314","article-title":"Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis","volume":"64","author":"Chiba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.4049\/jimmunol.1302701","article-title":"Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus","volume":"193","author":"Cho","year":"2014","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ni.3854","article-title":"Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes","volume":"18","author":"Rouxel","year":"2017","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fimmu.2015.00503","article-title":"Mucosal-associated invariant T Cells in multiple sclerosis: the jury is still out","volume":"6","author":"Treiner","year":"2015","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.1701213","article-title":"Production of IL-17 by MAIT cells is increased in multiple sclerosis and is associated with IL-7 receptor expression","volume":"200","author":"Willing","year":"2018","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/intimm\/dxn111","article-title":"Invariant V 7.2-J 33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.","volume":"20","author":"Peterfalvi","year":"2008","journal-title":"Int Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.4049\/jimmunol.1500258","article-title":"Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-\u03b3","volume":"195","author":"Sundstr\u00f6m","year":"2015","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00262-015-1764-7","article-title":"Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients","volume":"64","author":"Zabijak","year":"2015","journal-title":"Cancer Immunol Immunother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"76274","DOI":"10.18632\/oncotarget.11187","article-title":"Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer","volume":"7","author":"Won","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","first-page":"20358","DOI":"10.1038\/srep20358","article-title":"Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients","volume":"6","author":"Ling","year":"2016","journal-title":"Sci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1038\/s41598-018-22130-1","article-title":"Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma","volume":"8","author":"Gherardin","year":"2018","journal-title":"Sci Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.immuni.2018.03.009","article-title":"Unconventional T cell targets for cancer immunotherapy","volume":"48","author":"Godfrey","year":"2018","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/mi.2014.81","article-title":"MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets","volume":"8","author":"Kurioka","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/JLB.4RI0118-023R","article-title":"MAIT cell-mediated cytotoxicity: roles in host defense and therapeutic potentials in infectious diseases and cancer","volume":"104","author":"Rudak","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00262-016-1826-5","article-title":"Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma","volume":"65","author":"Noble","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.celrep.2014.09.045","article-title":"CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages","author":"Fergusson","year":"2014","journal-title":"Cell Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0889-8553(02)00016-X","article-title":"The epidemic of esophageal adenocarcinoma","volume":"31","author":"el-Serag","year":"2002","journal-title":"Gastroenterol Clin North Am."},{"key":"B27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/cncr.24760","article-title":"Annual report to the nation on the status of cancer, 1975\u20132006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates","volume":"116","author":"Edwards","year":"2010","journal-title":"Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Edgren","year":"2013","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.radonc.2006.01.009","article-title":"Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response","volume":"78","author":"Geh","year":"2006","journal-title":"Radiother Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/bjs.7100","article-title":"Association of visceral adiposity with oesophageal and junctional adenocarcinomas","volume":"97","author":"Beddy","year":"2010","journal-title":"Br J Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41575-018-0069-7","article-title":"Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments","volume":"15","author":"O'Sullivan","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/medicines4030067","article-title":"Esophageal cancer: genomic and molecular characterization, stem cell compartment and clonal evolution","volume":"4","author":"Testa","year":"2017","journal-title":"Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000341498","article-title":"Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer","volume":"29","author":"Picardo","year":"2012","journal-title":"Dig Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00241","article-title":"Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II\/III colorectal cancer patients who benefit from adjuvant chemotherapy","volume":"2018","author":"Allen","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/PPO.0000000000000185","article-title":"Immune checkpoint therapy and the search for predictive biomarkers","volume":"22","author":"Sharma","year":"2016","journal-title":"Cancer J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e76008","DOI":"10.1371\/journal.pone.0076008","article-title":"Persistent changes in circulating and intestinal \u03b3\u03b4 T cell subsets, invariant natural killer T cells and mucosal-associated invariant t cells in children and adults with coeliac disease","volume":"8","author":"Dunne","year":"2013","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e83474","DOI":"10.1371\/journal.pone.0083474","article-title":"Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV\/TB co-infection","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS ONE"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.4049\/jimmunol.1402945","article-title":"Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity","volume":"194","author":"Carolan","year":"2015","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ags3.12014","article-title":"Review of the gut microbiome and esophageal cancer: pathogenesis and potential clinical implications","volume":"1","author":"Baba","year":"2017","journal-title":"Ann Gastroenterol Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/apt.12317","article-title":"Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?","volume":"37","author":"Blackett","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","article-title":"Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury","volume":"137","author":"Souza","year":"2009","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1038\/cti.2016.30","article-title":"Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis","volume":"5","author":"Sayej","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"63669","DOI":"10.18632\/oncotarget.11611","article-title":"Expression of immune checkpoints in T cells of esophageal cancer patients","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/bjc.2014.416","article-title":"PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fonc.2016.00050","article-title":"Enrichment of inflammatory IL-17 and TNF-\u03b1 secreting CD4(+) T cells within colorectal tumors despite the presence of elevated CD39(+) T regulatory cells and increased expression of the immune checkpoint molecule, PD-1","volume":"6","author":"Dunne","year":"2016","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/eji.201040959","article-title":"Expression and function of PD-1 in human \u03b3\u03b4 T cells that recognize phosphoantigens","volume":"41","author":"Iwasaki","year":"2011","journal-title":"Eur J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1158\/1078-0432.CCR-06-1454","article-title":"Decreased NKG2D expression on CD8 + T cell is involved in immune evasion in patients with gastric cancer","volume":"13","author":"Osaki","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.2147\/OTT.S152513","article-title":"Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy","volume":"11","author":"Mehta","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2018.01.039","article-title":"Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma","volume":"418","author":"Galvin","year":"2018","journal-title":"Cancer Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00262-017-2050-7","article-title":"Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment","volume":"66","author":"Shaler","year":"2017","journal-title":"Cancer Immunol Immunother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","article-title":"Protumor vs antitumor functions of IL-17","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e984547","DOI":"10.4161\/2162402X.2014.984547","article-title":"The correlations between IL-17 vs","volume":"4","author":"Punt","year":"2015","journal-title":"Oncoimmunology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"436307","DOI":"10.1155\/2013\/436307","article-title":"Interleukin-17: a promoter in colorectal cancer progression","volume":"2013","author":"Wu","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2015.10.019","article-title":"Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma","volume":"370","author":"Kavanagh","year":"2016","journal-title":"Cancer Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/bjc.2014.46","article-title":"Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis","volume":"110","author":"Mei","year":"2014","journal-title":"Br J Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1096\/fj.201800052RR","article-title":"Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders","volume":"32","author":"Touch","year":"2018","journal-title":"FASEB J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1238541","DOI":"10.1080\/2162402X.2016.1238541","article-title":"CCL22-specific T cells: modulating the immunosuppressive tumor microenvironment","volume":"5","author":"Martinenaite","year":"2016","journal-title":"Oncoimmunology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fimmu.2018.01076","article-title":"Mucosal-associated invariant T cells are depleted and exhibit altered chemokine receptor expression and elevated granulocyte macrophage-colony stimulating factor production during end-stage renal disease","volume":"9","author":"Juno","year":"2018","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"98487","DOI":"10.1172\/jci.insight.98487","article-title":"Human MAIT cells exit peripheral tissues and recirculate via lymph in steady state conditions","volume":"3","author":"Voillet","year":"2018","journal-title":"JCI insight"},{"key":"B65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1200\/JCO.2017.74.9846","article-title":"Safety and antitumor activity of the anti-programmed death-1 antibody pembrolizumab in patients with advanced esophageal carcinoma","volume":"36","author":"Doi","year":"2018","journal-title":"J Clin Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e180013","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest."},{"key":"B71","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00262-017-1983-1","article-title":"HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients","volume":"66","author":"Dunne","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1593\/neo.131568","article-title":"HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker","volume":"16","author":"Sconocchia","year":"2014","journal-title":"Neoplasia"},{"key":"B73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1084\/jem.20111413","article-title":"Ovarian cancer progression is controlled by phenotypic changes in dendritic cells","volume":"209","author":"Scarlett","year":"2012","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccell.2018.03.008","article-title":"The immune revolution: a case for priming, not checkpoint","volume":"33","author":"Vonderheide","year":"2018","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00262-018-2132-1","article-title":"Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?","volume":"67","author":"Haeryfar","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri.2018.4","article-title":"Cancer immunotherapy in 2017: the breakthrough of the microbiota","volume":"18","author":"Kroemer","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1371\/journal.pbio.1000054","article-title":"Stepwise development of MAIT cells in mouse and human","volume":"7","author":"Martin","year":"2009","journal-title":"PLoS Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01580\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:30:35Z","timestamp":1562718635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01580\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2019.01580"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01580","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"article-number":"1580"}}